Beta
39664

Antitumor Effect of Mesenchymal Stem Cells from Murine in Breast Cancer in Female Rats

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

Biochemistry

Abstract

The aim of this study was to evaluate the effect of mesenchymal stem cells as a treatment against breast cancer via modulation TGF-β.
Mesenchymal stem cells (MSCs) are recruited to the stroma of cancers. They interact with cancer cells to promote invasion and metastasis or to suppress tumor growth. The unique
tumor-homing capacity of MSCs makes them a promising vehicle to deliver various anticancer agents.

DOI

10.21608/bvmj.2018.39664

Authors

First Name

Omayma

Last Name

A.R. AbouZaid

MiddleName

-

Affiliation

of Clinical Biochemistry, Faculty of Veterinary Medicine, Benha University

Email

-

City

-

Orcid

-

First Name

Laila

Last Name

A Rashed

MiddleName

-

Affiliation

Department of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt

Email

-

City

-

Orcid

-

First Name

S. M.

Last Name

El-Sonbaty

MiddleName

-

Affiliation

Assistant Professor Microbiology department, National center for Radiation Research and Technology ,Atomic Energy Authority, Cairo, Egypt,

Email

-

City

-

Orcid

-

First Name

Aboel-Ftouh

Last Name

A. I

MiddleName

-

Affiliation

Biochemistry department, Faculty of Veterinary Medicine, Benha University

Email

-

City

-

Orcid

-

Volume

35

Article Issue

1

Related Issue

5726

Issue Date

2018-09-01

Receive Date

2019-07-08

Publish Date

2018-09-01

Page Start

369

Page End

374

Print ISSN

1110-6581

Link

https://bvmj.journals.ekb.eg/article_39664.html

Detail API

https://bvmj.journals.ekb.eg/service?article_code=39664

Order

37

Type

Original Article

Type Code

812

Publication Type

Journal

Publication Title

Benha Veterinary Medical Journal

Publication Link

https://bvmj.journals.ekb.eg/

MainTitle

Antitumor Effect of Mesenchymal Stem Cells from Murine in Breast Cancer in Female Rats

Details

Type

Article

Created At

22 Jan 2023